Adjuvant activities of immune response modifier R-848: Comparison with CpG ODN

Cellular Immunology

Volumn 204, Issue 1, 2000, Pages 64-74

  Vasilakos, John P ^a   Smith, Rose M A ^a   Gibson, Sheila J ^a   Lindh, Jana M ^a   Pederson, Linda K ^a   Reiter, Michael J ^a   Smith, Michael H ^a   Tomai, Mark A ^a  

^a 3M COMPANY   (United States)

Author keywords

Cytokines; Immunomodulators; Isotype switching; Th1 Th2; Vaccination

Indexed keywords

ALPHA INTERFERON; ALUMINUM HYDROXIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; INTERLEUKIN 12; OLIGONUCLEOTIDE; OVALBUMIN; RESIQUIMOD; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; FEMALE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION;

EID: 0033775777     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2000.1689     Document Type: Article

References (41)

1. Heterogeneity of cytokine secretion patterns and functions of helper T cells
2. The comparative selectivity of adjuvants for humoral and cell mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour Ags I of the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide, and saponin
3. T-cell subsets and cytokines in parasitic infections
4. Adjuvant action of bacterial endotoxins on Ab formation: A historical perspective
5. Studies on the adjuvant action of bacterial endotoxins on Ab formation. IV. Enhancement of Ab formation by nucleic acids
6. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan subunits
7. CpG oligonucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
8. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor Ag immunization
9. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein Ag: A new class of vaccine adjuvants
10. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface Ag
11. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines
12. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
13. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface Ag in young mice
14. Polyinosinic acid: Polycytidylic acid promotes T helper type I-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12
15. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
16. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs
17. Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea pigs
18. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
19. Post-therapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs
20. Imiquimod 5% cream (Aldara(TM))
21. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod
22. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609
23. Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848
24. Cytokine induction by the immunomodulators imiquimod and S-27609
25. Immunomodulating and antiviral activities of the imidazoquinoline S-28463
26. Cytokine induction in mice by the immunomodulator imiquimod
27. + T cells in the pathogenesis of organ-specific autoimmune diseases
28. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
29. Induction of NK activity in murine and human cells by CpG motifs in oligonucleotides and bacterial DNA
30. Long term prevention of allergic inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
31. CpG motifs in bacterial DNA trigger direct B cell activation
32. Antagonism of immunostimulatory CpG oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds
33. Mechanism and function of a newly identified CpG DNA motif in human primary B cells
34. Lymphokine control of in vivo immunoglobulin isotype selection
35. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice
36. + T cell recruitment into tissues
37. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines
38. Differential regulation of Ag-induced IL-4 and IL-13 generation from T-lymphocytes by IFN-alpha
39. Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development
40. Interleukin-12 profoundly up-regulates the synthesis of Ag-specific complement-fixing IgG2a, IgG2b, and IgG3 Ab subclasses in vivo
41. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin